JP2024545184A5 - - Google Patents
Info
- Publication number
- JP2024545184A5 JP2024545184A5 JP2024534648A JP2024534648A JP2024545184A5 JP 2024545184 A5 JP2024545184 A5 JP 2024545184A5 JP 2024534648 A JP2024534648 A JP 2024534648A JP 2024534648 A JP2024534648 A JP 2024534648A JP 2024545184 A5 JP2024545184 A5 JP 2024545184A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- heteroaryl
- aryl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025137487A JP2025170331A (ja) | 2021-12-09 | 2025-08-21 | メニン－ｍｌｌ相互作用の阻害剤 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163287716P | 2021-12-09 | 2021-12-09 | |
| US63/287,716 | 2021-12-09 | ||
| US202263306399P | 2022-02-03 | 2022-02-03 | |
| US63/306,399 | 2022-02-03 | ||
| US202263397322P | 2022-08-11 | 2022-08-11 | |
| US63/397,322 | 2022-08-11 | ||
| PCT/US2022/052404 WO2023107696A2 (en) | 2021-12-09 | 2022-12-09 | Inhibitors of menin-mll interaction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025137487A Division JP2025170331A (ja) | 2021-12-09 | 2025-08-21 | メニン－ｍｌｌ相互作用の阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545184A JP2024545184A (ja) | 2024-12-05 |
| JP2024545184A5 true JP2024545184A5 (https=) | 2025-08-29 |
Family
ID=86731242
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534648A Pending JP2024545184A (ja) | 2021-12-09 | 2022-12-09 | メニン－ｍｌｌ相互作用の阻害剤 |
| JP2025137487A Pending JP2025170331A (ja) | 2021-12-09 | 2025-08-21 | メニン－ｍｌｌ相互作用の阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025137487A Pending JP2025170331A (ja) | 2021-12-09 | 2025-08-21 | メニン－ｍｌｌ相互作用の阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20250163061A1 (https=) |
| EP (1) | EP4444300A4 (https=) |
| JP (2) | JP2024545184A (https=) |
| KR (2) | KR20250135350A (https=) |
| AU (2) | AU2022405438A1 (https=) |
| CA (1) | CA3240074A1 (https=) |
| JO (1) | JOP20240130A1 (https=) |
| MX (2) | MX2024007069A (https=) |
| TW (2) | TW202529770A (https=) |
| WO (1) | WO2023107696A2 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1246593A1 (zh) * | 2015-06-04 | 2018-09-14 | Kura Oncology, Inc. | 用於抑制menin蛋白与mll蛋白的相互作用的方法及组合物 |
| AU2016378579A1 (en) * | 2015-12-22 | 2018-06-14 | Vitae Pharmaceuticals, Inc. | Inhibitors of the menin-MLL interaction |
| EP3684361A4 (en) * | 2017-09-20 | 2021-09-08 | Kura Oncology, Inc. | SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHOD OF USING |
-
2022
- 2022-12-08 TW TW113134963A patent/TW202529770A/zh unknown
- 2022-12-08 TW TW111147241A patent/TW202337435A/zh unknown
- 2022-12-09 MX MX2024007069A patent/MX2024007069A/es unknown
- 2022-12-09 KR KR1020257029621A patent/KR20250135350A/ko active Pending
- 2022-12-09 CA CA3240074A patent/CA3240074A1/en active Pending
- 2022-12-09 JP JP2024534648A patent/JP2024545184A/ja active Pending
- 2022-12-09 AU AU2022405438A patent/AU2022405438A1/en active Pending
- 2022-12-09 EP EP22905177.6A patent/EP4444300A4/en active Pending
- 2022-12-09 KR KR1020247022800A patent/KR20240117133A/ko active Pending
- 2022-12-09 WO PCT/US2022/052404 patent/WO2023107696A2/en not_active Ceased
- 2022-12-09 US US18/717,973 patent/US20250163061A1/en active Pending
-
2024
- 2024-06-07 MX MX2025012108A patent/MX2025012108A/es unknown
- 2024-06-10 JO JOJO/P/2024/0130A patent/JOP20240130A1/ar unknown
-
2025
- 2025-08-21 JP JP2025137487A patent/JP2025170331A/ja active Pending
- 2025-09-09 AU AU2025230651A patent/AU2025230651A1/en active Pending
- 2025-09-19 US US19/334,801 patent/US20260022120A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102866499B1 (ko) | Tead 전사인자의 신규한 소분자 저해제 | |
| JP6805220B2 (ja) | 治療上活性な化合物およびそれらの使用方法 | |
| AU2018358157B2 (en) | Modulators of the integrated stress pathway | |
| ES2660831T3 (es) | Derivados de imidazol condensados útiles como inhibidores de IDO | |
| JP6031122B2 (ja) | 抗微生物療法のための三環式ホウ素化合物 | |
| AU2018358346A1 (en) | Modulators of the integrated stress pathway | |
| RU2717577C2 (ru) | Производное имидазоизоиндола, способ его получения и медицинское применение | |
| WO2020223536A1 (en) | Substituted cyclolakyls as modulators of the integrated stress pathway | |
| JP7595004B2 (ja) | 甲状腺ホルモン受容体ベータアゴニスト化合物 | |
| EP3807251B1 (en) | Phenyl and pyridinyl substituted imidazoles as modulators of roryt | |
| BR112020008817B1 (pt) | Compostos moduladores da via de estresse integrada referência cruzada a pedidos relacionados | |
| RU2013128448A (ru) | Производные триазола в качестве ингибиторов сигнального пути wnt | |
| CA2901022A1 (en) | Substituted pyridine compounds as inhibitors of histone demethylases | |
| EP3774755B1 (en) | Spirocyclic compounds as modulators of indoleamine 2,3-dioxygenase | |
| TW202342027A (zh) | Prmt5-mta抑制劑 | |
| JP2020516616A5 (https=) | ||
| EP2906564A1 (en) | Treating brain cancer using agelastatin a (aa) and analogues thereof | |
| JP2025118609A (ja) | Ｎｕｒｒ１受容体調節因子 | |
| JP5614858B2 (ja) | 新規コルチスタチンａ類似体およびその用途 | |
| CA3134405A1 (en) | Thienoheterocyclic derivative, preparation method therefor and medical use thereof | |
| CN109956927A (zh) | 苯并咪唑类衍生物、其制备方法及其在医药学上的应用 | |
| JP2017137323A (ja) | 新規抗がん剤 | |
| CN111518077A (zh) | 一种新型抗肿瘤ido抑制剂的制备方法 | |
| TWI827576B (zh) | 吲哚胺2,3-雙加氧酶抑制劑以及它們在醫學上的應用 | |
| JP2024545184A5 (https=) |